chr12-5494432-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001102654.2(NTF3):c.257A>T(p.Glu86Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001102654.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NTF3 | NM_001102654.2 | c.257A>T | p.Glu86Val | missense_variant | 2/2 | ENST00000423158.4 | |
NTF3 | NM_002527.5 | c.218A>T | p.Glu73Val | missense_variant | 1/1 | ||
NTF3 | XM_011520963.3 | c.218A>T | p.Glu73Val | missense_variant | 2/2 | ||
NTF3 | XM_047428901.1 | c.218A>T | p.Glu73Val | missense_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NTF3 | ENST00000423158.4 | c.257A>T | p.Glu86Val | missense_variant | 2/2 | 1 | NM_001102654.2 | P4 | |
NTF3 | ENST00000331010.7 | c.218A>T | p.Glu73Val | missense_variant | 1/1 | A1 | |||
NTF3 | ENST00000543548.1 | n.447A>T | non_coding_transcript_exon_variant | 2/2 | 3 | ||||
NTF3 | ENST00000535299.5 | n.232-12133A>T | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 12, 2024 | The c.218A>T (p.E73V) alteration is located in exon 1 (coding exon 1) of the NTF3 gene. This alteration results from a A to T substitution at nucleotide position 218, causing the glutamic acid (E) at amino acid position 73 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.